
95% of researchers rate our articles as excellent or good
Learn more about the work of our research integrity team to safeguard the quality of each article we publish.
Find out more
CORRECTION article
Front. Mol. Biosci. , 23 September 2021
Sec. Molecular Diagnostics and Therapeutics
Volume 8 - 2021 | https://doi.org/10.3389/fmolb.2021.664616
This article is part of the Research Topic Engineering Signal Sensors Based on Reprogrammed CRISPR Technologies View all 23 articles
This article is a correction to:
Silencing of lncRNA MIR497HG via CRISPR/Cas13d Induces Bladder Cancer Progression Through Promoting the Crosstalk Between Hippo/Yap and TGF-β/Smad Signaling
A corrigendum on
by Zhuang, C., Liu, Y., Fu, S., Yuan, C., Luo, J., Huang, X., Yang, W., Xie, W., Zhuang, C. (2020), Front Mol Biosci. 7:616768. doi: 10.3389/fmolb.2020.616768
In the original article (Zhuang et al., 2020), there were two errors in Supplementary Figure 2. The “T24 Wound Healing” images of 24 h of “ctrl” in Supplementary Figure 2D and the Supplementary Figure 2F (right) mistakenly used the 5,637 cells data. We then proceed to re-check all original data, found that the inadvertent errors happened during figure processing. All the original pictures of Wound Healing and migration assays of 5,637 and T24 cells were put in a same folder for faster processing and mistakes were happened in the process of image processing using Adobe Illustrator CS6. The authors truly apologize for the oversight on this matter to the editors, reviewers and readers for any confusion that has been caused by these unintentional errors.
The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.
Zhuang, C., Liu, Y., Fu, S., Yuan, C., Luo, J., Huang, X., et al. (2020). Silencing of lncRNA MIR497HG via CRISPR/Cas13d Induces bladder cancer progression through promoting the Crosstalk between hippo/yap and TGF-β/smad signaling. Front. Mol. Biosci. 7, 616768. doi:10.3389/fmolb.2020.616768.eCollection2020 |
Keywords: bladder cancer, MIR497HG, CRISPR/Cas13days, YAP, TGF-b
Citation: Zhuang C, Liu Y, Fu S, Yuan C, Luo J, Huang X, Yang W, Xie W and Zhuang C (2021) Corrigendum: Silencing of lncRNA MIR497HG via CRISPR/Cas13d Induces Bladder Cancer Progression Through Promoting the Crosstalk Between Hippo/Yap and TGF-β/Smad Signaling. Front. Mol. Biosci. 8:664616. doi: 10.3389/fmolb.2021.664616
Received: 05 February 2021; Accepted: 16 February 2021;
Published: 23 September 2021.
Edited and Reviewd by:
Yuchen Liu, Shenzhen University, ChinaCopyright © 2021 Zhuang, Liu, Fu, Yuan, Luo, Huang, Yang, Xie and Zhuang. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Chengle Zhuang, Y2x6aHVhbmdAcGt1LmVkdS5jbg==; Wuwei Xie, MjUzNjYzMTUzQHFxLmNvbQ==
†These authors have contributed equally to this work.
Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
Research integrity at Frontiers
Learn more about the work of our research integrity team to safeguard the quality of each article we publish.